03/03/2020 17:09 (UTC)

PharmaMar sube el 15,3 % en bolsa tras anunciar pruebas para el coronavirus

(Actualiza EC2375 con el cierre en bolsa y el dividendo)

Madrid, 3 mar (EFE).- La biofarmacéutica española PharmaMar se ha disparado un 15,30 por ciento al cierre en bolsa, hasta 4,396 euros, tras...

Metadata

Date: 03/03/2020 17:09 (UTC)
Credit: EFE
Source: EFE
Topic: Health » Disease » Communicable diseases
Economy, business and finance » Macro economics » Business enterprises
Economy, business and finance » Financial and business service » Market research
Economy, business and finance » Chemicals » Pharmaceutical
Reference: 18010045659
Relevance: Normal

Content included in the following products:

Efedata